Markets:

Overview

News

Currencies

International

Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

6.755 +0.025 (+0.37%)

Streaming Delayed Price Updated: 2:58 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference

July 08, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 25, 2021

Gainers Osmotica Pharmaceuticals (NASDAQ:OSMT) stock increased by 39.78% to $3.97 during Friday's regular session. The current volume of 48.4 million shares is 18988....

Via Benzinga

What 9 Analyst Ratings Have To Say About Taysha Gene Therapies ↗

June 24, 2021

Taysha Gene Therapies (NASDAQ:TSHA) has observed the follo...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗

June 24, 2021

Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:

Via Benzinga

Taysha Gene Therapies Announces Publication of Natural History Data for TSHA-120 in Giant Axonal Neuropathy in the Journal, Brain

June 21, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Host Virtual R&D Day

June 17, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Analyst Ratings for Taysha Gene Therapies ↗

June 15, 2021

Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1...

Via Benzinga

Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum

June 15, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Earnings Scheduled For May 11, 2021 ↗

May 11, 2021

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

Taysha Gene Therapies to Host First Annual Stockholder Meeting

June 10, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Expert Ratings for Taysha Gene Therapies ↗

June 09, 2021

Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 1 0...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021 ↗

June 09, 2021

Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ:KLAC) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2021 ↗

June 08, 2021

Upgrades According to Seaport Global, the prior rating for CMC Materials Inc (NASDAQ:CCMP) was changed from Neutral to Buy. CMC Materials earned $1.71 in the second...

Via Benzinga

Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences

May 26, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2021 ↗

May 19, 2021

Upgrades For Agilysys Inc (NASDAQ:AGYS), Craig-Hallum upgraded the previous rating of Hold to Buy. Agilysys earned $0.21 in the fourth quarter, compared to $0.05 in the...

Via Benzinga

Taysha Gene Therapies Joins the Rare Disease Company Coalition

May 19, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development Officer

May 13, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences

May 12, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies, Inc. (TSHA) Q1 2021 Earnings Call Transcript ↗

May 11, 2021

TSHA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

May 11, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

Taysha Gene Therapies' Rett Syndrome Candidate Shows Encouraging Action In Animal Studies, Human Trial To Start By 2021 ↗

May 10, 2021

Taysha Gene Therapies Inc (NASDAQ: TSHA) has announced the online publication of new preclinical data for TSHA-102 in Rett syndrome. The data will be included in...

Via Benzinga

Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed Journal

May 10, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies Announces Multiple Data Presentations and Workshop Presentations at the 24th Annual Meeting of the American Society of Gene & Cell Therapy

May 05, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11

May 04, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs and Upcoming R&D Day

April 14, 2021

From Taysha Gene Therapies, Inc.

Via Business Wire

55 Biggest Movers From Yesterday ↗

April 13, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.